InvestorsHub Logo
Followers 10
Posts 1578
Boards Moderated 0
Alias Born 10/15/2014

Re: matthewverymuch post# 7582

Thursday, 02/18/2016 3:15:45 PM

Thursday, February 18, 2016 3:15:45 PM

Post# of 16893
At the JP Morgan conference, Braeburn's materials projected approval for chronic pain in 3Q 2018. Assuming they got priority review (6 months), that would mean the Phase IIIs would have to end by 4Q 2017 at the latest (probably 3Q). Which means Phase III's would probably need to begin recruiting in 3Q 2016...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News